readthroughSign in
CompanyINABNasdaqNew York, NY

In8bio Inc.

IN8bio develops γδ T cell and γδ T cell engager product candidates for oncology and autoimmune indications.

Stories only
SEC EDGARClinicalTrials.govin8bio.com
424B3Aug 14Latest SEC filing
Aug 6Latest story

August 2026